Details

Autor(en) / Beteiligte

• SCHEINERT, Dierk
• KATSANOS, Konstantinos
• VAN RANSBEECK, Mariella
• QURESHI, Ayesha C
• STOLL, Hans-Peter
• ZELLER, Thomas
• KOPPENSTEINER, Renate
• COMMEAU, Philip
• BOSIERS, Marc
• KRANKENBERG, Hans
• BAUMGARTNER, Iris
• SIABLIS, Dimitris
• LAMMER, Johannes

Titel

A Prospective Randomized Multicenter Comparison of Balloon Angioplasty and Infrapopliteal Stenting With the Sirolimus-Eluting Stent in Patients With Ischemic Peripheral Arterial Disease: 1-Year Results From the ACHILLES Trial

Ist Teil von

• Journal of the American College of Cardiology, 2012-12, Vol.60 (22), p.2290-2295

Ort / Verlag

New York, NY: Elsevier

Erscheinungsjahr

2012

Quelle

MEDLINE

Beschreibungen/Notizen

• The study investigated the efficacy and safety of a balloon expandable, sirolimus-eluting stent (SES) in patients with symptomatic infrapopliteal arterial disease. Results of infrapopliteal interventions using balloon angioplasty and/or bare stents are limited by a relatively high restenosis rate, which could be potentially improved by stabilizing the lesion with a SES. Two hundred patients (total lesion length 27 ± 21 mm) were randomized to infrapopliteal SES stenting or percutaneous transluminal balloon angioplasty (PTA). The primary endpoint was 1-year in-segment binary restenosis by quantitative angiography. Ninety-nine and 101 patients (mean age 73.4 years; 64% diabetics) were randomized to SES and PTA, respectively (8 crossover bailout cases to SES). At 1 year, there were lower angiographic restenosis rates (22.4% vs. 41.9%, p = 0.019), greater vessel patency (75.0% vs. 57.1%, p =0.025), and similar death, repeat revascularization, index-limb amputation rates, and proportions of patients with improved Rutherford class for SES versus PTA. SES implantation may offer a promising therapeutic alternative to PTA for treatment of infrapopliteal peripheral arterial disease.